123 related articles for article (PubMed ID: 34192844)
1. [Analysis of the reported data of National Cervical Cancer Screening Program in Rural Areas in China from 2009 to 2018].
Zhao YX; Ma L; Ren WH; Song B; Wang LH; Di JL; Wu JL
Zhonghua Yi Xue Za Zhi; 2021 Jun; 101():1863-1868. PubMed ID: 34192844
[No Abstract] [Full Text] [Related]
2. [Analysis of the reported data of national rural cervical cancer screening project from 2012 to 2013, China].
Luo XM; Song L; Wu JL; Liu Y; Di JL; Song B; Zheng RM; Ma L
Zhonghua Yu Fang Yi Xue Za Zhi; 2016 Apr; 50(4):346-50. PubMed ID: 27029367
[TBL] [Abstract][Full Text] [Related]
3. [Real-world research on cervical cancer screening program and effect evaluation for Chinese population].
Zhao YQ; Dai Y; Dang L; Kong LH; Zhang Y; Feng RM; Qiao YL; Lang JH
Zhonghua Zhong Liu Za Zhi; 2018 Oct; 40(10):764-771. PubMed ID: 30392341
[No Abstract] [Full Text] [Related]
4. Effectiveness of High-risk Human Papillomavirus Testing for Cervical Cancer Screening in China: A Multicenter, Open-label, Randomized Clinical Trial.
Zhang J; Zhao Y; Dai Y; Dang L; Ma L; Yang C; Li Y; Kong L; Wei L; Zhang S; Liu J; Xi M; Chen L; Duan X; Xiao Q; Abulizi G; Zhang G; Hong Y; Gao X; Zhou Q; Xie X; Li L; Niyazi M; Zhang Z; Tuo J; Ding Y; Si M; Chen F; Song L; Qiao Y; Lang J
JAMA Oncol; 2021 Feb; 7(2):263-270. PubMed ID: 33377903
[TBL] [Abstract][Full Text] [Related]
5. Knowledge of Cervical Cancer Screening among Women across Different Socio-Economic Regions of China.
Di J; Rutherford S; Wu J; Song B; Ma L; Chen J; Chu C
PLoS One; 2015; 10(12):e0144819. PubMed ID: 26657110
[TBL] [Abstract][Full Text] [Related]
6. Conventional Pap smear cervical cancer screening in 11 rural counties in Hainan Province, China: analysis of Bethesda system reporting rates for 218,195 women (predominantly ages 35-64 years) screened in China's National Cervical Cancer Screening Program in Rural Areas (NCCSPRA).
Zheng B; Austin RM; Liang X; Wei G; You J; Liang Y; Zhao C
J Am Soc Cytopathol; 2017; 6(3):120-125. PubMed ID: 31043262
[TBL] [Abstract][Full Text] [Related]
7. [Three-year follow-up results of visual inspection with acetic acid/Lugol's iodine (VIA/VILI) used as an alternative screening method for cervical cancer in rural areas].
Zhang YZ; Ma JF; Zhao FH; Xiang XE; Ma ZH; Shi YT; Hu SY; Qiao YL
Chin J Cancer; 2010 Jan; 29(1):4-8. PubMed ID: 20038302
[TBL] [Abstract][Full Text] [Related]
8. [Study on the value assessment of various screening programs regarding cervical cancer screening strategy in the rural areas of China].
Li LY; Qiao ZQ; Zhang MF; Yang JP; Bao YP; An YT; Lei J; Xiong NH; Yu XH; Zhang X; Pan QJ; Qiao YL
Zhonghua Liu Xing Bing Xue Za Zhi; 2007 Oct; 28(10):964-7. PubMed ID: 18399140
[TBL] [Abstract][Full Text] [Related]
9. [Comparison of high-risk human papillomavirus infection rate and genotype distribution between Han and Mongolian women].
Zhao S; Zhao XL; Hu SY; Wang Y; Remila R; Xu XQ; Duan XZ; Chen F; Zhang X; Zhao FH
Zhonghua Liu Xing Bing Xue Za Zhi; 2019 Nov; 40(11):1439-1444. PubMed ID: 31838818
[No Abstract] [Full Text] [Related]
10. Changes in High-Risk HPV Infection Prevalence and Associated Factors in Selected Rural Areas of China: A Multicenter Population-Based Study.
Yu YQ; Jiang MY; Dang L; Feng RM; Bangura MS; Chen W; Qiao YL
Front Med (Lausanne); 2022; 9():911367. PubMed ID: 35903319
[TBL] [Abstract][Full Text] [Related]
11. [Comparison of screening performance between primary high-risk HPV screening and high-risk HPV screening plus liquid-based cytology cotesting in diagnosis of cervical precancerous or cancerous lesions].
Zhao XL; Remila R; Hu SY; Zhang L; Xu XQ; Chen F; Pan QJ; Zhang X; Zhao FH
Zhonghua Yu Fang Yi Xue Za Zhi; 2018 May; 52(5):469-474. PubMed ID: 29747337
[No Abstract] [Full Text] [Related]
12. Cervical screening with primary HPV testing or cytology in a population of women in which those aged 33 years or younger had previously been offered HPV vaccination: Results of the Compass pilot randomised trial.
Canfell K; Caruana M; Gebski V; Darlington-Brown J; Heley S; Brotherton J; Gertig D; Jennett CJ; Farnsworth A; Tan J; Wrede CD; Castle PE; Saville M
PLoS Med; 2017 Sep; 14(9):e1002388. PubMed ID: 28926579
[TBL] [Abstract][Full Text] [Related]
13. Real-world effectiveness of primary screening with high-risk human papillomavirus testing in the cervical cancer screening programme in China: a nationwide, population-based study.
Zhao Y; Bao H; Ma L; Song B; Di J; Wang L; Gao Y; Ren W; Wang S; Wang HJ; Wu J
BMC Med; 2021 Jul; 19(1):164. PubMed ID: 34261463
[TBL] [Abstract][Full Text] [Related]
14. Human papillomavirus distribution and cervical cancer epidemiological characteristics in rural population of Xinjiang, China.
Wang Y; Cai YB; James W; Zhou JL; Rezhake R; Zhang Q
Chin Med J (Engl); 2021 Jul; 134(15):1838-1844. PubMed ID: 34267066
[TBL] [Abstract][Full Text] [Related]
15. Knowledge of Cervical Cancer Screening among Health Care Workers Providing Services Across Different Socio-economic Regions of China.
Di JL; Rutherford S; Wu JL; Song B; Ma L; Chen JY; Chu C
Asian Pac J Cancer Prev; 2016; 17(6):2965-72. PubMed ID: 27356719
[TBL] [Abstract][Full Text] [Related]
16. Factors associated with high-risk HPV infection and cervical cancer screening methods among rural Uyghur women aged > 30 years in Xinjiang.
Husaiyin S; Han L; Wang L; Ma C; Ainiwaer Z; Rouzi N; Akemujiang M; Simayil H; Aniwa Z; Nurimanguli R; Niyazi M
BMC Cancer; 2018 Nov; 18(1):1162. PubMed ID: 30470207
[TBL] [Abstract][Full Text] [Related]
17. [The Clinical Significance of HPV L1/PD-L1 Tests Combined with Colposcopy for Cervical Precancerous Lesions and Cervical Cancer].
Luo GP; Zeng X; Cao HY; Tang D; Xi MR
Sichuan Da Xue Xue Bao Yi Xue Ban; 2021 May; 52(3):516-522. PubMed ID: 34018374
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of portable colposcopy and human papillomavirus testing for screening of cervical cancer in rural China.
Newman H; Hu J; Li X; He J; Bradford L; Shan S; Wu X; Zhu B; Yang W; Fu B; Zhu B; Gao G
Int J Gynecol Cancer; 2019 Jan; 29(1):23-27. PubMed ID: 30640679
[TBL] [Abstract][Full Text] [Related]
19. [Prevalence of high-risk HPV and its distribution in cervical precancerous lesions among 35-64 years old women who received cervical cancer screening in Beijing].
Shen J; Gao LL; Zhang Y; Han LL; Wang JD
Zhonghua Yu Fang Yi Xue Za Zhi; 2018 May; 52(5):493-497. PubMed ID: 29747341
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
